anavar for women

Antifungal agent for topical application, with a wide range of antifungal activity. At low concentrations terbinafine has fungicidal activity against dermatophytes, (Trichophyton rubrum, T.mentagrophytes, T.verrucosum , T.violaceum, Microsporum canis, Epidermophyton floccosum), mold (mainly C. albicans) and certain dimorphic fungi (Pityrosporum orbiculare) . Activity against yeast fungi, depending on their type, may be a fungicidal or fungistatic.

Terbinafine changes occurring ergosterol biosynthesis in fungi by inhibiting squalene epoxidase enzyme located on the cell membrane of the fungus. This leads to a deficiency of ergosterol and to an intracellular accumulation of squalene, which causes death of fungal cells.

Terbinafine has no effect on the cytochrome anavar for women system in humans and, therefore, the metabolism of hormones or other drugs.

Pharmacokinetics. When applied topically absorption – less than 5% has little systemic effect.


Indications for use:

  • prevention and treatment of fungal skin infections, including fungal infections stop ( “mushroom” foot), jock itch (tinea cruris), fungal infections of the skin smooth body (tinea corporis), caused by dermatophytes such as Trichophyton (including, T.rubrum , T.mentagrophytes, T.verrucosum, T.violaceum), Microsporum canis and Epidermophyton floccosum.
  • yeast infections of the skin caused mainly by fungi of the genus Candida (e.g., Candida albicans), in particular diaper rash.
  • pityriasis versicolor (Pityriasis versicolor), called Pityrosporum orbiculare (also known as Malassezia furfur).

: Hypersensitivity to terbinafine or to any of the inactive components of the composition of the drug.

Precautions: hepatic and / or renal failure, alcoholism, depression of bone marrow hematopoiesis, tumors, metabolic diseases, limb occlusive vascular disease, children under 12 years anavar for women of age (lack of sufficient clinical experience).

Pregnancy and lactation. In experimental research teratogenic properties of terbinafine have been identified. So far no reports of any malformation when applying Terbinoksa. However, as clinical experience with Terbinoksa in pregnant women is very limited, it should be used only on strict conditions.

Terbinafine is excreted in breast milk, however when using the drug nursing mother any negative impact on the child is unlikely because systemic absorption through the skin cream is very small.

Dosage and administration:
Adults and children from 12 years:

should be clean and dry the affected area before applying the cream. The cream is applied thinly to the affected skin and surrounding areas 1 or 2 times a day and gently rubbed. For infections involving intertrigo (under the breasts, in the interdigital spaces, between the buttocks, groin), cream application site can cover the gauze, especially at night.

The average duration of treatment: Tinea torso, legs: 1 week 1 time per day. Tinea pedis: . 1 week 1 time per day Skin Candidiasis: 1-2 weeks 1 or 2 times a day. Colorful versicolor: 2 weeks 1 or 2 times day.

The reduction or disappearance of the main anavar for women clinical manifestations of the disease is usually observed in the first days of therapy. In the case of irregular treatment or premature discontinuation of treatment there is a risk of renewed infection. If after 1-2 weeks of treatment, improvement of disease symptoms were observed, there should be verified diagnosis.

The dosage regimen of the drug in the elderly is not different from the above.

Use of the drug in children
is not recommended to use the drug in children under 12 years old.

Side Effects
In rare cases, the site of application of the drug may appear redness, itching or burning. Allergic reactions.

So far, cases of overdose have been reported. If accidentally Terbinoks cream is ingested, it is possible to expect development of the same side effects as an overdose of pills Terbinoks (headache, nausea, epigastric pain and dizziness).
Treatment: activated charcoal, if necessary – symptomatic supportive therapy.

are any drug interactions are not known for Terbinoksa cream.

Reducing the severity of clinical manifestations are usually noted in the first days of treatment. Irregular use or premature ending of treatment increases the risk of recurrent infection.

The drug is intended for external use only, so you should avoid getting the cream on the mucous membrane of eyes, because it can cause irritation.

In case of accidental contact with the drug immediately wash out the eye with running water, and in the case of persistent phenomena of irritation consult a doctor. With the development anavar for women of allergic reactions need to stop the drug.

If the drug has come into disrepair or expiration date – do not throw it in the waste water